首页 > 最新文献

Gut microbiome (Cambridge, England)最新文献

英文 中文
The gut microbiota is an emerging target for improving brain health during ageing. 肠道微生物群是改善老年期大脑健康的一个新兴目标。
Pub Date : 2023-01-01 Epub Date: 2022-12-12 DOI: 10.1017/gmb.2022.11
Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox

The gut microbiota plays crucial roles in maintaining the health and homeostasis of its host throughout lifespan, including through its ability to impact brain function and regulate behaviour during ageing. Studies have shown that there are disparate rates of biologic ageing despite equivalencies in chronologic age, including in the development of neurodegenerative diseases, which suggests that environmental factors may play an important role in determining health outcomes in ageing. Recent evidence demonstrates that the gut microbiota may be a potential novel target to ameliorate symptoms of brain ageing and promote healthy cognition. This review highlights the current knowledge around the relationships between the gut microbiota and host brain ageing, including potential contributions to age-related neurodegenerative diseases. Furthermore, we assess key areas for which gut microbiota-based strategies may present as opportunities for intervention.

肠道微生物群在维持宿主整个生命周期的健康和平衡方面发挥着至关重要的作用,包括通过其在衰老过程中影响大脑功能和调节行为的能力。研究表明,尽管实际年龄相同,但生物老化的速度却有差异,包括神经退行性疾病的发病率,这表明环境因素可能在决定老化过程中的健康结果方面发挥着重要作用。最近的证据表明,肠道微生物群可能是改善脑老化症状和促进健康认知的潜在新目标。本综述重点介绍了目前有关肠道微生物群与宿主大脑老化之间关系的知识,包括对与年龄相关的神经退行性疾病的潜在贡献。此外,我们还评估了基于肠道微生物群的策略可能提供干预机会的关键领域。
{"title":"The gut microbiota is an emerging target for improving brain health during ageing.","authors":"Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox","doi":"10.1017/gmb.2022.11","DOIUrl":"10.1017/gmb.2022.11","url":null,"abstract":"<p><p>The gut microbiota plays crucial roles in maintaining the health and homeostasis of its host throughout lifespan, including through its ability to impact brain function and regulate behaviour during ageing. Studies have shown that there are disparate rates of biologic ageing despite equivalencies in chronologic age, including in the development of neurodegenerative diseases, which suggests that environmental factors may play an important role in determining health outcomes in ageing. Recent evidence demonstrates that the gut microbiota may be a potential novel target to ameliorate symptoms of brain ageing and promote healthy cognition. This review highlights the current knowledge around the relationships between the gut microbiota and host brain ageing, including potential contributions to age-related neurodegenerative diseases. Furthermore, we assess key areas for which gut microbiota-based strategies may present as opportunities for intervention.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"4 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9845519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Habitual Intake of Probiotic Supplements and Yogurt with Characteristics of the Gut Microbiome in the Multiethnic Cohort Adiposity Phenotype Study. 多民族肥胖表型研究中益生菌补充剂和酸奶的习惯性摄入与肠道微生物组特征的关系
Pub Date : 2023-01-01 Epub Date: 2023-07-13 DOI: 10.1017/gmb.2023.10
Weiwen Chai, Gertraud Maskarinec, Unhee Lim, Carol J Boushey, Lynne R Wilkens, V Wendy Setiawan, Loïc Le Marchand, Timothy W Randolph, Isaac C Jenkins, Johanna W Lampe, Meredith A J Hullar

Consumption of probiotics and/or yogurt could be a solution for restoring the balance of the gut microbiota. This study examined associations of regular intake of probiotic supplements or yogurt with the gut microbiota among a diverse population of older adults (N=1,861; 60-72 years). Fecal microbial composition was obtained from 16S rRNA gene sequencing (V1-V3 region). General Linear Models were used to estimate the associations of probiotic supplement or yogurt intake with microbiome measures adjusting for covariates. Compared to non-yogurt consumers (N=1,023), regular yogurt consumers (≥once/week, N=818) had greater Streptococcus (β=0.29, P=0.0003) and lower Odoribacter (β=-0.33, P<0.0001) abundance. The directions of the above associations were consistent across the five ethnic groups but stronger among Japanese Americans (Streptococcus: β=0.56, P=0.0009; Odoribacter: β=-0.62, P=0.0005). Regular intake of probiotic supplements (N=175) was not associated with microbial characteristics (i.e., alpha diversity and the abundance of 152 bacteria genera). Streptococcus is one of the predominant bacteria genera in yogurt products, which may explain the positive association between yogurt consumption and Streptococcus abundance. Our analyses suggest that changes in Odoribacter were independent of changes in Streptococcus abundance. Future studies may investigate whether these microbial genera and their sub-level species mediate potential pathways between yogurt consumption and health.

摘要食用益生菌和/或酸奶可能是恢复肠道微生物群平衡的解决方案。这项研究调查了不同年龄段老年人(N=1861;60-72岁)定期摄入益生菌补充剂或酸奶与肠道微生物群的关系。粪便微生物组成通过16S rRNA基因测序获得(V1–V3区域)。使用一般线性模型来估计益生菌补充剂或酸奶摄入量与调整协变量的微生物组测量的相关性。与非酸奶消费者(N=1023)相比,普通酸奶消费者(≥1次/周,N=818)的链球菌丰度较高(β=0.29,P=0.0003),气味杆菌丰度较低(β=-0.33,P<0.0001)。上述关联的方向在五个种族中是一致的,但在日裔美国人中更强(链球菌:β=0.56,P=0.0009;气味杆菌:β=-0.62,P=0.0005)。经常摄入益生菌补充剂(N=175)与微生物特征(即α多样性和152个细菌属的丰度)无关。链球菌是酸奶产品中的主要细菌属之一,这可以解释酸奶消费量与链球菌丰度之间的正相关关系。我们的分析表明,气味杆菌的变化与链球菌丰度的变化无关。未来的研究可能会调查这些微生物属及其次级物种是否介导酸奶消费和健康之间的潜在途径。
{"title":"Association of Habitual Intake of Probiotic Supplements and Yogurt with Characteristics of the Gut Microbiome in the Multiethnic Cohort Adiposity Phenotype Study.","authors":"Weiwen Chai, Gertraud Maskarinec, Unhee Lim, Carol J Boushey, Lynne R Wilkens, V Wendy Setiawan, Loïc Le Marchand, Timothy W Randolph, Isaac C Jenkins, Johanna W Lampe, Meredith A J Hullar","doi":"10.1017/gmb.2023.10","DOIUrl":"10.1017/gmb.2023.10","url":null,"abstract":"<p><p>Consumption of probiotics and/or yogurt could be a solution for restoring the balance of the gut microbiota. This study examined associations of regular intake of probiotic supplements or yogurt with the gut microbiota among a diverse population of older adults (N=1,861; 60-72 years). Fecal microbial composition was obtained from 16S rRNA gene sequencing (V1-V3 region). General Linear Models were used to estimate the associations of probiotic supplement or yogurt intake with microbiome measures adjusting for covariates. Compared to non-yogurt consumers (N=1,023), regular yogurt consumers (≥once/week, N=818) had greater <i>Streptococcus</i> (β=0.29, <i>P</i>=0.0003) and lower <i>Odoribacter</i> (β=-0.33, <i>P</i><0.0001) abundance. The directions of the above associations were consistent across the five ethnic groups but stronger among Japanese Americans (<i>Streptococcus:</i> β=0.56, <i>P</i>=0.0009; <i>Odoribacter:</i> β=-0.62, <i>P</i>=0.0005). Regular intake of probiotic supplements (N=175) was not associated with microbial characteristics (i.e., alpha diversity and the abundance of 152 bacteria genera). <i>Streptococcus</i> is one of the predominant bacteria genera in yogurt products, which may explain the positive association between yogurt consumption and <i>Streptococcus</i> abundance. Our analyses suggest that changes in <i>Odoribacter</i> were independent of changes in <i>Streptococcus</i> abundance. Future studies may investigate whether these microbial genera and their sub-level species mediate potential pathways between yogurt consumption and health.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45518410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The gut microbiome in children with mood, anxiety, and neurodevelopmental disorders: An umbrella review 患有情绪、焦虑和神经发育障碍儿童的肠道微生物群:综述
Pub Date : 2023-01-01 DOI: 10.1017/gmb.2023.16
Kaitlin Romano, Ashka N Shah, Anett Schumacher, Clare Zasowski, Tianyi Zhang, Glyneva Bradley-Ridout, Kaitlyn Merriman, John Parkinson, Peter Szatmari, Susan C Campisi, Daphne J Korczak
Abstract Research on the gut microbiome and mental health among children and adolescents is growing. This umbrella review provides a high-level overview of current evidence syntheses to amalgamate current research and inform future directions. Searches were conducted across seven databases for peer-reviewed pediatric (<18 years) review literature. Studies reporting gut microbiome composition and/or biotic supplementation on depression, bipolar disorder, anxiety, attention deficit hyperactivity disorder, autism spectrum disorder (ASD), or obsessive-compulsive disorder (OCD) were included. Deduplication and screening took place in Covidence. A sensitivity analysis was conducted to assess the degree of primary study overlap. Among the 39 included review studies, 23 (59%) were observational and 16 (41%) were interventional. Most reviews (92%) focused on ASD. Over half (56%) of the observational and interventional reviews scored low or critically low for methodological quality. A higher abundance of Clostridium clusters and a lower abundance of Bifidobacterium were consistently observed in ASD studies. Biotic supplementation was associated with ASD symptom improvement. Gut microbiome-mental health evidence syntheses in child and youth depression, anxiety, bipolar disorder, and OCD are lacking. Preliminary evidence suggests an association between specific microbiota and ASD symptoms, with some evidence supporting a role for probiotic supplementation ASD therapy.
儿童和青少年肠道微生物群与心理健康的研究越来越多。这一总括性综述提供了当前证据综合的高水平概述,以合并当前的研究并告知未来的方向。在7个数据库中检索了同行评议的儿科(18年)综述文献。研究报告了肠道微生物组组成和/或生物补充剂对抑郁症、双相情感障碍、焦虑、注意缺陷多动障碍、自闭症谱系障碍(ASD)或强迫症(OCD)的影响。在疫情期间进行了重复数据删除和筛选。进行敏感性分析以评估主要研究重叠的程度。在纳入的39项综述研究中,23项(59%)为观察性研究,16项(41%)为干预性研究。大多数评论(92%)集中在ASD上。超过一半(56%)的观察性和干预性评价在方法学质量上得分较低或极低。在ASD研究中一致观察到较高丰度的梭菌群和较低丰度的双歧杆菌。生物补充剂与ASD症状改善相关。儿童和青少年抑郁症、焦虑症、双相情感障碍和强迫症的肠道微生物群-心理健康综合证据缺乏。初步证据表明,特定微生物群与ASD症状之间存在关联,一些证据支持益生菌补充ASD治疗的作用。
{"title":"The gut microbiome in children with mood, anxiety, and neurodevelopmental disorders: An umbrella review","authors":"Kaitlin Romano, Ashka N Shah, Anett Schumacher, Clare Zasowski, Tianyi Zhang, Glyneva Bradley-Ridout, Kaitlyn Merriman, John Parkinson, Peter Szatmari, Susan C Campisi, Daphne J Korczak","doi":"10.1017/gmb.2023.16","DOIUrl":"https://doi.org/10.1017/gmb.2023.16","url":null,"abstract":"Abstract Research on the gut microbiome and mental health among children and adolescents is growing. This umbrella review provides a high-level overview of current evidence syntheses to amalgamate current research and inform future directions. Searches were conducted across seven databases for peer-reviewed pediatric (<18 years) review literature. Studies reporting gut microbiome composition and/or biotic supplementation on depression, bipolar disorder, anxiety, attention deficit hyperactivity disorder, autism spectrum disorder (ASD), or obsessive-compulsive disorder (OCD) were included. Deduplication and screening took place in Covidence. A sensitivity analysis was conducted to assess the degree of primary study overlap. Among the 39 included review studies, 23 (59%) were observational and 16 (41%) were interventional. Most reviews (92%) focused on ASD. Over half (56%) of the observational and interventional reviews scored low or critically low for methodological quality. A higher abundance of Clostridium clusters and a lower abundance of Bifidobacterium were consistently observed in ASD studies. Biotic supplementation was associated with ASD symptom improvement. Gut microbiome-mental health evidence syntheses in child and youth depression, anxiety, bipolar disorder, and OCD are lacking. Preliminary evidence suggests an association between specific microbiota and ASD symptoms, with some evidence supporting a role for probiotic supplementation ASD therapy.","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"298 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135595975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MetaFunc: Taxonomic and Functional Analyses of High Throughput Sequencing for Microbiomes MetaFunc:微生物组高通量测序的分类和功能分析
Pub Date : 2023-01-01 DOI: 10.1017/gmb.2022.12
Arielle Kae Sulit, Tyler Kolisnik, Frank A Frizelle, Rachel Purcell, Sebastian Schmeier
Abstract The identification of functional processes taking place in microbiome communities augment traditional microbiome taxonomic studies, giving a more complete picture of interactions taking place within the community. While there are applications that perform functional annotation on metagenomes or metatranscriptomes, very few of these are able to link taxonomic identity to function or are limited by their input types or databases used. Here we present MetaFunc, a workflow which takes RNA sequences as input reads, and from these (1) identifies species present in the microbiome sample and (2) provides gene ontology annotations associated with the species identified. In addition, MetaFunc allows for host gene analysis, mapping the reads to a host genome, and separating these reads, prior to microbiome analyses. Differential abundance analysis for microbe taxonomies, and differential gene expression analysis and gene set enrichment analysis may then be carried out through the pipeline. A final correlation analysis between microbial species and host genes can also be performed. Finally, MetaFunc builds an R shiny application that allows users to view and interact with the microbiome results. In this paper, we showed how MetaFunc can be applied to metatranscriptomic datasets of colorectal cancer.
微生物群落中发生的功能过程的鉴定增强了传统的微生物群落分类学研究,为群落内发生的相互作用提供了更完整的图景。虽然有一些应用程序可以对宏基因组或元转录组进行功能性注释,但这些应用程序很少能够将分类身份与功能联系起来,或者受到输入类型或使用的数据库的限制。在这里,我们提出了MetaFunc,这是一个以RNA序列作为输入读取的工作流程,并从中(1)识别微生物组样本中存在的物种,(2)提供与所识别物种相关的基因本体注释。此外,MetaFunc允许宿主基因分析,绘制宿主基因组的reads,并在微生物组分析之前分离这些reads。微生物分类的差异丰度分析、差异基因表达分析和基因集富集分析可以通过管道进行。微生物种类和宿主基因之间的最终相关性分析也可以进行。最后,MetaFunc构建了一个R shiny应用程序,允许用户查看微生物组结果并与之交互。在本文中,我们展示了MetaFunc如何应用于结直肠癌的亚转录组数据集。
{"title":"MetaFunc: Taxonomic and Functional Analyses of High Throughput Sequencing for Microbiomes","authors":"Arielle Kae Sulit, Tyler Kolisnik, Frank A Frizelle, Rachel Purcell, Sebastian Schmeier","doi":"10.1017/gmb.2022.12","DOIUrl":"https://doi.org/10.1017/gmb.2022.12","url":null,"abstract":"Abstract The identification of functional processes taking place in microbiome communities augment traditional microbiome taxonomic studies, giving a more complete picture of interactions taking place within the community. While there are applications that perform functional annotation on metagenomes or metatranscriptomes, very few of these are able to link taxonomic identity to function or are limited by their input types or databases used. Here we present MetaFunc, a workflow which takes RNA sequences as input reads, and from these (1) identifies species present in the microbiome sample and (2) provides gene ontology annotations associated with the species identified. In addition, MetaFunc allows for host gene analysis, mapping the reads to a host genome, and separating these reads, prior to microbiome analyses. Differential abundance analysis for microbe taxonomies, and differential gene expression analysis and gene set enrichment analysis may then be carried out through the pipeline. A final correlation analysis between microbial species and host genes can also be performed. Finally, MetaFunc builds an R shiny application that allows users to view and interact with the microbiome results. In this paper, we showed how MetaFunc can be applied to metatranscriptomic datasets of colorectal cancer.","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135077882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Towards the characterization of sustainable diet’s gut microbiota composition and functions 可持续饮食肠道菌群组成及功能的研究
Pub Date : 2023-01-01 DOI: 10.1017/gmb.2023.13
Mariana Lares-Michel, Zyanya Reyes-Castillo, Fatima Ezzahra Housni
Abstract The gut microbiome is a key element for health preservation and disease prevention. Nevertheless, defining a healthy gut microbiome is complex since it is modulated by several factors, such as host genetics, sex, age, geographical zone, drug use, and, especially, diet. Although a healthy diet has proven to increase microbial alpha and beta diversity and to promote the proliferation of health-related bacteria, considering the current environmental and nutritional crisis, such as climate change, water shortage, loss of diversity, and the obesity pandemic, it should be highlighted that a healthy diet is not always sustainable. Sustainable diets are dietary patterns that promote all dimensions of people’s health and well-being while exerting low pressure on the environment, and being accessible, affordable, safe, equitable, and culturally acceptable. Examples of diets that tend to be sustainable are the Planetary Health Diet of the EAT-Lancet Commission or territorial diets such as the Mediterranean and the Traditional Mexican diet (milpa diet), adapted to specific contexts. These diets are principally plant-based but include small or moderate amounts of animal-based foods. Characterising the effects of sustainable diets on gut microbiota is urgent to ensure that the benefits for human health are aligned with environmental preservation and respect the sociocultural aspects of individuals.
肠道微生物群是保持健康和预防疾病的关键因素。然而,定义一个健康的肠道微生物群是复杂的,因为它受到几个因素的调节,如宿主遗传、性别、年龄、地理区域、药物使用,尤其是饮食。虽然健康的饮食已被证明可以增加微生物α和β的多样性,并促进与健康有关的细菌的增殖,但考虑到当前的环境和营养危机,如气候变化、水资源短缺、多样性丧失和肥胖大流行,应该强调的是,健康的饮食并不总是可持续的。可持续饮食是一种饮食模式,可促进人们健康和福祉的各个方面,同时对环境施加的压力较小,并且可获得、负担得起、安全、公平且在文化上可接受。可持续性饮食的例子有EAT-Lancet委员会的全球健康饮食,或适合具体情况的地域饮食,如地中海饮食和传统墨西哥饮食(milpa饮食)。这些饮食主要是植物性的,但也包括少量或适量的动物性食物。迫切需要描述可持续饮食对肠道微生物群的影响,以确保对人类健康的益处与环境保护相一致,并尊重个人的社会文化方面。
{"title":"Towards the characterization of sustainable diet’s gut microbiota composition and functions","authors":"Mariana Lares-Michel, Zyanya Reyes-Castillo, Fatima Ezzahra Housni","doi":"10.1017/gmb.2023.13","DOIUrl":"https://doi.org/10.1017/gmb.2023.13","url":null,"abstract":"Abstract The gut microbiome is a key element for health preservation and disease prevention. Nevertheless, defining a healthy gut microbiome is complex since it is modulated by several factors, such as host genetics, sex, age, geographical zone, drug use, and, especially, diet. Although a healthy diet has proven to increase microbial alpha and beta diversity and to promote the proliferation of health-related bacteria, considering the current environmental and nutritional crisis, such as climate change, water shortage, loss of diversity, and the obesity pandemic, it should be highlighted that a healthy diet is not always sustainable. Sustainable diets are dietary patterns that promote all dimensions of people’s health and well-being while exerting low pressure on the environment, and being accessible, affordable, safe, equitable, and culturally acceptable. Examples of diets that tend to be sustainable are the Planetary Health Diet of the EAT-Lancet Commission or territorial diets such as the Mediterranean and the Traditional Mexican diet (milpa diet), adapted to specific contexts. These diets are principally plant-based but include small or moderate amounts of animal-based foods. Characterising the effects of sustainable diets on gut microbiota is urgent to ensure that the benefits for human health are aligned with environmental preservation and respect the sociocultural aspects of individuals.","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135360957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut physiology meets microbiome science. 肠道生理学与微生物组科学的结合。
Pub Date : 2022-12-12 eCollection Date: 2023-01-01 DOI: 10.1017/gmb.2022.10
Hannelore Daniel

Research on the gut microbiome has gained high popularity and almost every disease has meanwhile been linked to alterations in microbiome composition. Typically assessed via stool samples, the microbiome displays a huge diversity with a multitude of environmental parameters already identified as contributing to its character. Despite impressive scientific progress, normal microbiome diversity remains largely unexplained and it is tempting to speculate some of the yet unexplained variance is hidden in normal gut physiology. Although a few genome/phenome-wide associations studies have recently highlighted physiological parameters such as stool frequency, known as contributing to microbiome diversity, there is a large knowledge base from decades of basic research on gut functions that can be explored for possible links to stool features and microbiome characteristics. And, when extrapolating findings from faecal samples to the biology in the intestinal lumen or the mucosal microenvironment, gut anatomy and physiology features need to be considered. Similarly, differences in anatomy and physiology between rodents and humans need attention when discussing findings in animals in relation to human physiology and nutrition.

对肠道微生物组的研究已获得广泛关注,几乎所有疾病都与微生物组组成的改变有关。微生物组通常通过粪便样本进行评估,微生物组显示出巨大的多样性,许多环境参数已被确认对微生物组的特性有影响。尽管取得了令人瞩目的科学进展,但正常微生物组的多样性在很大程度上仍然无法解释,人们不禁猜测,一些尚未解释的差异隐藏在正常的肠道生理中。虽然最近有一些全基因组/表型组关联研究强调了大便频率等生理参数,认为它们有助于微生物组多样性的形成,但数十年来有关肠道功能的基础研究积累了大量知识,可以探索大便特征与微生物组特征之间可能存在的联系。此外,在将粪便样本的研究结果推断为肠道内腔或粘膜微环境中的生物特征时,还需要考虑肠道解剖和生理特征。同样,在讨论与人类生理和营养有关的动物研究结果时,也需要注意啮齿动物和人类在解剖学和生理学方面的差异。
{"title":"Gut physiology meets microbiome science.","authors":"Hannelore Daniel","doi":"10.1017/gmb.2022.10","DOIUrl":"https://doi.org/10.1017/gmb.2022.10","url":null,"abstract":"<p><p>Research on the gut microbiome has gained high popularity and almost every disease has meanwhile been linked to alterations in microbiome composition. Typically assessed via stool samples, the microbiome displays a huge diversity with a multitude of environmental parameters already identified as contributing to its character. Despite impressive scientific progress, normal microbiome diversity remains largely unexplained and it is tempting to speculate some of the yet unexplained variance is hidden in normal gut physiology. Although a few genome/phenome-wide associations studies have recently highlighted physiological parameters such as stool frequency, known as contributing to microbiome diversity, there is a large knowledge base from decades of basic research on gut functions that can be explored for possible links to stool features and microbiome characteristics. And, when extrapolating findings from faecal samples to the biology in the intestinal lumen or the mucosal microenvironment, gut anatomy and physiology features need to be considered. Similarly, differences in anatomy and physiology between rodents and humans need attention when discussing findings in animals in relation to human physiology and nutrition.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"4 ","pages":"e1"},"PeriodicalIF":0.0,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the metabolic fate of human milk oligosaccharides: it may just be more complex than you think? 确定母乳低聚糖的代谢命运:它可能比你想象的更复杂?
Pub Date : 2022-09-07 eCollection Date: 2022-01-01 DOI: 10.1017/gmb.2022.8
Peter Philip James Jackson, Anisha Wijeyesekera, Robert Adrian Rastall

Human milk oligosaccharides (HMOs) are a class of structurally diverse and complex unconjugated glycans present in breast milk, which act as selective substrates for several genera of select microbes and inhibit the colonisation of pathogenic bacteria. Yet, not all infants are breastfed, instead being fed with formula milks which may or may not contain HMOs. Currently, formula milks only possess two HMOs: 2'-fucosyllactose (2'FL) and lacto-N-neotetraose (LNnT), which have been suggested to be similarly effective as human breast milk in supporting age-related growth. However, the in vivo evidence regarding their ability to beneficially reduce respiratory infections along with altering the composition of an infant's microbiota is limited at best. Thus, this review will explore the concept of HMOs and their metabolic fate, and summarise previous in vitro and in vivo clinical data regarding HMOs, with specific regard to 2'FL and LNnT.

母乳低聚糖(HMO)是母乳中存在的一类结构多样且复杂的非偶联聚糖,它是几个属的特定微生物的选择性底物,并抑制病原菌的定植。然而,并不是所有的婴儿都是母乳喂养的,而是用可能含有或不含有HMO的配方奶喂养的。目前,配方奶只含有两种HMO:2 0-岩藻糖基乳糖(2’FL)和乳糖-N-新三糖(LNnT),它们被认为在支持与年龄相关的生长方面与母乳一样有效。然而,关于它们在改变婴儿微生物群组成的同时有益地减少呼吸道感染的能力的体内证据充其量是有限的。因此,本综述将探讨HMO的概念及其代谢命运,并总结先前关于HMO的体外和体内临床数据,特别是关于2'FL和LNnT的数据。Fuc和唾液酸部分与所测试的双歧杆菌的B.longum bv.infantis ATCC 15697,B.breve ATCC 1570仅能在适度使用Fuc的情况下实现中等水平的生长,而B.youdescentis和B.bifidum ATCC 15696在Fuc或唾液酸上均未表现出生长。这些与Garrido等人(2015)、世卫组织婴儿配方奶粉(Berger等人,2020)的记录相似。对照母乳喂养的参考组分析结果,通过16S rRNA基因测序分析3个月和12个月时微生物群落类型的变化。结果表明,与母乳喂养的参考组相比,含HMO的配方奶粉刺激了双歧杆菌的增加,尽管程度低于母乳喂养的对照组。然而,与对照组相比,含HMO配方奶粉组的大肠杆菌水平显著降低,并且与母乳喂养的双歧杆菌科的大肠杆菌相对丰度相似,以及导致拟杆菌科和双歧杆菌科相对于Lachnospiraceae和Ruminococceae扩增子测序变体P的对数比更高。这些结果有助于解释在婴儿粪便样本中检测到的HMO的存在和水平的巨大可变性,即使考虑到分泌状态,几乎没有发现潜在的HMO。意见/观点包括
{"title":"Determining the metabolic fate of human milk oligosaccharides: it may just be more complex than you think?","authors":"Peter Philip James Jackson, Anisha Wijeyesekera, Robert Adrian Rastall","doi":"10.1017/gmb.2022.8","DOIUrl":"10.1017/gmb.2022.8","url":null,"abstract":"<p><p>Human milk oligosaccharides (HMOs) are a class of structurally diverse and complex unconjugated glycans present in breast milk, which act as selective substrates for several genera of select microbes and inhibit the colonisation of pathogenic bacteria. Yet, not all infants are breastfed, instead being fed with formula milks which may or may not contain HMOs. Currently, formula milks only possess two HMOs: 2'-fucosyllactose (2'FL) and lacto-<i>N</i>-neotetraose (LNnT), which have been suggested to be similarly effective as human breast milk in supporting age-related growth. However, the <i>in vivo</i> evidence regarding their ability to beneficially reduce respiratory infections along with altering the composition of an infant's microbiota is limited at best. Thus, this review will explore the concept of HMOs and their metabolic fate, and summarise previous <i>in vitro</i> and <i>in vivo</i> clinical data regarding HMOs, with specific regard to 2'FL and LNnT.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"1 1","pages":"e9"},"PeriodicalIF":0.0,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44414633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. 调节肠道微环境作为肠易激综合征的治疗策略:叙述性回顾
Pub Date : 2022-08-25 eCollection Date: 2022-01-01 DOI: 10.1017/gmb.2022.6
Cristina Iribarren, Lujain Maasfeh, Lena Öhman, Magnus Simrén

Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction with a complex pathophysiology. Growing evidence suggests that alterations of the gut microenvironment, including microbiota composition and function, may be involved in symptom generation. Therefore, attempts to modulate the gut microenvironment have provided promising results as an indirect approach for IBS management. Antibiotics, probiotics, prebiotics, food and faecal microbiota transplantation are the main strategies for alleviating IBS symptom severity by modulating gut microbiota composition and function (eg. metabolism), gut barrier integrity and immune activity, although with varying efficacy. In this narrative review, we aim to provide an overview of the current approaches targeting the gut microenvironment in order to indirectly manage IBS symptoms.

摘要肠易激综合征(IBS)是一种具有复杂病理生理学的肠脑相互作用障碍。越来越多的证据表明,肠道微环境的改变,包括微生物群的组成和功能,可能与症状的产生有关。因此,调节肠道微环境的尝试作为IBS管理的间接方法提供了有希望的结果。抗生素、益生菌、益生元、食物和粪便微生物群移植是通过调节肠道微生物群组成和功能(如代谢)、肠道屏障完整性和免疫活性来缓解IBS症状严重程度的主要策略,尽管疗效各不相同。在这篇叙述性综述中,我们旨在概述目前针对肠道微环境的方法,以间接管理IBS症状。
{"title":"Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review.","authors":"Cristina Iribarren, Lujain Maasfeh, Lena Öhman, Magnus Simrén","doi":"10.1017/gmb.2022.6","DOIUrl":"10.1017/gmb.2022.6","url":null,"abstract":"<p><p>Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction with a complex pathophysiology. Growing evidence suggests that alterations of the gut microenvironment, including microbiota composition and function, may be involved in symptom generation. Therefore, attempts to modulate the gut microenvironment have provided promising results as an indirect approach for IBS management. Antibiotics, probiotics, prebiotics, food and faecal microbiota transplantation are the main strategies for alleviating IBS symptom severity by modulating gut microbiota composition and function (eg. metabolism), gut barrier integrity and immune activity, although with varying efficacy. In this narrative review, we aim to provide an overview of the current approaches targeting the gut microenvironment in order to indirectly manage IBS symptoms.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":" ","pages":"e7"},"PeriodicalIF":0.0,"publicationDate":"2022-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45449338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The microbiome in adult acute appendicitis. 成人急性阑尾炎的微生物组
Pub Date : 2022-08-04 eCollection Date: 2022-01-01 DOI: 10.1017/gmb.2022.7
Mei Sze Lee, Arielle Sulit, Frank Frizelle, Rachel Purcell

Acute appendicitis is a common acute surgical emergency; however, the pathogenesis of adult appendicitis remains poorly understood. The microbiome is increasingly thought to play a key role in inflammatory disease of the bowel and similarly, may play a role in appendicitis. This study aimed to characterise the microbiome of adult acute appendicitis in a prospective cohort. We recruited 60 adults with acute appendicitis and 20 healthy controls. Rectal swabs were taken from each patient. After DNA extraction, 16S rRNA amplicon sequencing was carried out for analysis of diversity and taxonomic abundance. Phylogenetic sequencing of the samples indicated that there is a difference between the microbial composition of those with acute appendicitis and healthy controls, with a statistically significant decrease in alpha diversity in rectal swabs of appendicitis patients compared to healthy controls. At the genus level, we saw an increased abundance of potential pathogens, for example, Parvimonas and Acinetobacter, and a decrease in commensal taxa such as Faecalibacterium, Blautia and Lachnospiraceae in appendicitis patients compared to healthy controls. There was a reduction in diversity and loss of commensals in the microbiome of those with acute appendicitis, which may play a role in the cascade leading to acute appendicitis or the result of this.

摘要急性阑尾炎是常见的急性外科急症;然而,成人阑尾炎的发病机制仍然知之甚少。越来越多的人认为微生物群在肠道炎症性疾病中起着关键作用,类似地,可能在阑尾炎中起作用。这项研究的目的是在一个前瞻性队列中描述成人急性阑尾炎的微生物组。我们招募了60名患有急性阑尾炎的成年人和20名健康对照者。从每位患者身上取直肠拭子。提取DNA后,进行16S rRNA扩增子测序,分析其多样性和分类丰度。样本的系统发育测序表明,急性阑尾炎患者和健康对照者的微生物组成存在差异,阑尾炎患者直肠拭子中α多样性与健康对照者相比有统计学意义的显著降低。在属水平上,我们发现阑尾炎患者的潜在病原体(如细小单胞菌和不动杆菌)的丰度增加,而与健康对照组相比,共生类群(如Faecalibacterium, Blautia和Lachnospiraceae)的数量减少。急性阑尾炎患者的微生物群多样性减少,共栖物丧失,这可能在导致急性阑尾炎或其结果的级联反应中发挥作用。
{"title":"The microbiome in adult acute appendicitis.","authors":"Mei Sze Lee, Arielle Sulit, Frank Frizelle, Rachel Purcell","doi":"10.1017/gmb.2022.7","DOIUrl":"10.1017/gmb.2022.7","url":null,"abstract":"<p><p>Acute appendicitis is a common acute surgical emergency; however, the pathogenesis of adult appendicitis remains poorly understood. The microbiome is increasingly thought to play a key role in inflammatory disease of the bowel and similarly, may play a role in appendicitis. This study aimed to characterise the microbiome of adult acute appendicitis in a prospective cohort. We recruited 60 adults with acute appendicitis and 20 healthy controls. Rectal swabs were taken from each patient. After DNA extraction, 16S rRNA amplicon sequencing was carried out for analysis of diversity and taxonomic abundance. Phylogenetic sequencing of the samples indicated that there is a difference between the microbial composition of those with acute appendicitis and healthy controls, with a statistically significant decrease in alpha diversity in rectal swabs of appendicitis patients compared to healthy controls. At the genus level, we saw an increased abundance of potential pathogens, for example, <i>Parvimonas</i> and <i>Acinetobacter</i>, and a decrease in commensal taxa such as <i>Faecalibacterium, Blautia</i> and <i>Lachnospiraceae</i> in appendicitis patients compared to healthy controls. There was a reduction in diversity and loss of commensals in the microbiome of those with acute appendicitis, which may play a role in the cascade leading to acute appendicitis or the result of this.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":" ","pages":"e8"},"PeriodicalIF":0.0,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47023191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alterations in infant gut microbiome composition and metabolism after exposure to glyphosate and Roundup and/or a spore-based formulation using the SHIME technology. 接触草甘膦和 Roundup 和/或使用 SHIME 技术的孢子制剂后,婴儿肠道微生物组的组成和代谢发生变化。
Pub Date : 2022-07-26 eCollection Date: 2022-01-01 DOI: 10.1017/gmb.2022.5
Robin Mesnage, Marta Calatayud, Cindy Duysburgh, Massimo Marzorati, Michael N Antoniou

Despite extensive research into the toxicology of the herbicide glyphosate, there are still major unknowns regarding its effects on the human gut microbiome. We describe the effects of glyphosate and a Roundup glyphosate-based herbicide on infant gut microbiota using SHIME technology. SHIME microbiota culture was undertaken in the presence of a concentration of 100-mg/L glyphosate and the same glyphosate equivalent concentration of Roundup. Roundup and to a lesser extent glyphosate caused an increase in fermentation activity, resulting in acidification of the microbial environment. This was also reflected by an increase in lactate and acetate production concomitant to a decrease in the levels of propionate, valerate, caproate and butyrate. Ammonium production reflecting proteolytic activities was increased by Roundup exposure. Global metabolomics revealed large-scale disturbances, including an increased abundance of long-chain polyunsaturated fatty acids. Changes in bacterial composition measured by qPCR and 16S rRNA suggested that lactobacilli had their growth stimulated as a result of microenvironment acidification. Co-treatment with the spore-based probiotic formulation MegaSporeBiotic reverted some of the changes in short-chain fatty acid levels. Altogether, our results suggest that glyphosate can exert effects on human gut microbiota.

尽管对除草剂草甘膦的毒理学进行了广泛的研究,但其对人体肠道微生物群的影响仍是一个重大的未知数。我们利用 SHIME 技术描述了草甘膦和 Roundup 草甘膦除草剂对婴儿肠道微生物群的影响。在 100 毫克/升草甘膦浓度和相同草甘膦当量浓度的 Roundup 存在下进行 SHIME 微生物群培养。驱避剂和少量草甘膦引起了发酵活动的增加,导致微生物环境酸化。这也反映在乳酸盐和醋酸盐产量增加的同时,丙酸盐、戊酸盐、己酸盐和丁酸盐的含量下降。氨的产生反映了蛋白水解活动,而驱集素的暴露则增加了氨的产生。全球代谢组学显示了大规模的干扰,包括长链多不饱和脂肪酸含量的增加。通过 qPCR 和 16S rRNA 测定的细菌组成变化表明,微环境酸化刺激了乳酸菌的生长。使用孢子益生菌制剂 MegaSporeBiotic 进行联合处理后,短链脂肪酸水平的一些变化得到了逆转。总之,我们的研究结果表明草甘膦会对人体肠道微生物群产生影响。
{"title":"Alterations in infant gut microbiome composition and metabolism after exposure to glyphosate and Roundup and/or a spore-based formulation using the SHIME technology.","authors":"Robin Mesnage, Marta Calatayud, Cindy Duysburgh, Massimo Marzorati, Michael N Antoniou","doi":"10.1017/gmb.2022.5","DOIUrl":"https://doi.org/10.1017/gmb.2022.5","url":null,"abstract":"<p><p>Despite extensive research into the toxicology of the herbicide glyphosate, there are still major unknowns regarding its effects on the human gut microbiome. We describe the effects of glyphosate and a Roundup glyphosate-based herbicide on infant gut microbiota using SHIME technology. SHIME microbiota culture was undertaken in the presence of a concentration of 100-mg/L glyphosate and the same glyphosate equivalent concentration of Roundup. Roundup and to a lesser extent glyphosate caused an increase in fermentation activity, resulting in acidification of the microbial environment. This was also reflected by an increase in lactate and acetate production concomitant to a decrease in the levels of propionate, valerate, caproate and butyrate. Ammonium production reflecting proteolytic activities was increased by Roundup exposure. Global metabolomics revealed large-scale disturbances, including an increased abundance of long-chain polyunsaturated fatty acids. Changes in bacterial composition measured by qPCR and 16S rRNA suggested that lactobacilli had their growth stimulated as a result of microenvironment acidification. Co-treatment with the spore-based probiotic formulation MegaSporeBiotic reverted some of the changes in short-chain fatty acid levels. Altogether, our results suggest that glyphosate can exert effects on human gut microbiota.</p>","PeriodicalId":73187,"journal":{"name":"Gut microbiome (Cambridge, England)","volume":"3 ","pages":"e6"},"PeriodicalIF":0.0,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gut microbiome (Cambridge, England)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1